We want your views on proposed amendments to the Selected List Scheme (SLS) in Wales.
Consultation description
We want your views on proposed amendments to the Selected List Scheme (SLS) in Wales.
The SLS specifies medicines that may only be prescribed by general practitioners (GPs) on the NHS in clearly defined clinical circumstances.
The medicines covered by the SLS, and the circumstances in which they can be prescribed, are set out in Schedule 2 to the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) (Wales) Regulations 2004, as amended.
In practical terms, this means the SLS limits the prescribing of a small number of medicines by GPs in Wales to situations where:
- the benefits of using them are clear
and does not allow them to be prescribed where:
- the benefits are not as obvious
- there are potential risks
Consultation documents
Proposed amendments to the Selected List Scheme (SLS) in Wales: Integrated Impact Assessment , file type: PDF, file size: 126 KB
Proposed amendments to the Selected List Scheme (SLS) in Wales: Children's Rights Impact Assessment , file type: PDF, file size: 149 KB
Proposed amendments to the Selected List Scheme (SLS) in Wales: Welsh Language Impact Assessment , file type: PDF, file size: 131 KB
Proposed amendments to the Selected List Scheme (SLS) in Wales: Regulatory Impact Assessment , file type: PDF, file size: 102 KB
How to respond
Submit your comments by 17 December 2026, in any of the following ways:
Online form
Post
Download the response form.
Complete and return to:
Pharmacy and Prescribing Branch,
Welsh Government,
Cathays Park,
Cardiff,
CF10 3NQ
When you reply, it would be useful if you confirm whether you are replying as an individual or submitting an official response on behalf of an organisation and include:
- your name
- your position (if applicable)
- the name of organisation (if applicable)